Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Onco-Innovations Ltd. ( (TSE:ONCO) ) is now available.
Onco-Innovations Limited has successfully closed a non-brokered private placement, raising $2,000,000 by issuing 1,428,570 units at $1.40 per unit. The funds will be used for general corporate purposes, including operational, research and development, and investor relations objectives. The private placement also involved issuing warrants and administrative shares, with all securities subject to a statutory hold period. This financial move is expected to bolster Onco-Innovations’ operational capabilities and support its ongoing cancer research initiatives.
More about Onco-Innovations Ltd.
Onco-Innovations Limited is a Canadian-based company focused on cancer research and treatment, specializing in oncology. The company is committed to the prevention and treatment of cancer through pioneering research and innovative solutions, and holds an exclusive worldwide license to patented technology targeting solid tumors.
Average Trading Volume: 41,672
Technical Sentiment Signal: Strong Sell
Find detailed analytics on ONCO stock on TipRanks’ Stock Analysis page.